| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 5.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 2.700 | 20090826, Ebo DG
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 2.020 | 20110223, De Knop KJ
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 1.900 | 20130912, Lacerda Araujo LM
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | Bulgaria / Czech Republic / Lithuania / Poland | IgE | 56 | 7.000 | 20121112, Le TM
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 0.000 | 20111214, Zheng YW
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | France / Italy / Netherlands / Switzerland / United Kingdom | IgE | 181 | 9.000 | 20121112, Le TM
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 0.000 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 0.000 | 20091005, Ott H
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | Greece / Spain | IgE | 45 | 18.000 | 20121112, Le TM
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | Iceland | IgE | 29 | 4.000 | 20121112, Le TM
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 19699 | 0.530 | 20100909, Bernardi ML
| | 3.2.1 - Source Sensitized (IgE) | 2013 | Italy | IgE | 284 | 1.760 | 20130420, Palazzo P
| | 3.2.1 - Source Sensitized (IgE) | 2011 | Italy | IgE | 835 | 10.300 | 20110211, DAvino R
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Italy | IgE | 214 | 4.200 | 20110211, DAvino R
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Italy | IgE | 60 | 0.000 | 20110211, DAvino R
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Italy | IgE | 36 | 0.000 | 20130420, Palazzo P
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Italy | SPT | 36 | 5.550 | 20130420, Palazzo P
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy | SPT | 11 | 100.000 | 20100909, Bernardi ML
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 198 | 0.510 | 20101118, Bublin M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 237 | 2.530 | 20101118, Bublin M
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 0.500 | 20140331, Rockmann H
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Switzerland | IgE | 30 | 20.000 | 20100111, Bublin M
|
|
Loading...
Act d 5
